We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
There is no evidence from clinical or epidemiological studies that treatment with ACE-I or ARBs might worsen COVID-19 infection.
How to get in touch with the MHRA during this period.
More than 80 medicines used to treat patients in intensive care units have been banned from parallel export from the UK.
First published during the 2019 to 2022 Johnson Conservative government
The Medicines and Healthcare Products Regulatory Agency (MHRA) took part in the annual global coordinated operation to tackle the illegal online sale of medicines and medical devices.
Patients are urged to stop taking 5mg ulipristal acetate as soon as possible and contact a healthcare professional for advice on alternative treatments.
An application for a new flu vaccine by Sanofi Pasteur, designed to be more effective in the over-65 age group, was quickly approved for use from the 2019 to 2020 flu season.
Patients prescribed cannabis-based medicines will be able to get their treatment in days rather than months.
Patients who have recently been discharged from hospital will get greater support from local pharmacy teams to manage their medicines.
A pharmacist was today sentenced to 28 months in prison at the Birmingham Crown Court following an investigation by the MHRA.
The Medicines and Healthcare products Regulatory Agency (MHRA) launches a week long social media campaign to raise awareness about the importance of reporting suspected side effects using the Yellow Card Scheme.
The Medicines and Medical Devices Bill introduces new safety measures, increases the professions that can prescribe low-risk medicines and allows hospitals to develop personalised medicines.
Healthcare professionals can now use EMIS Web to report suspected adverse drug reactions to the Medicines and Healthcare products Regulatory Agency (MHRA).
MHRA helps Achilles Therapeutics treat non-small cell lung cancer through innovation.
Following an investigation by the Medicines & Healthcare products Regulatory Agency (MHRA) a man from north London has been sentenced to 6 years in prison at Croydon Crown Court.
MHRA investigation reveals illegally supplied opiate painkillers, tranquillisers and medications intended for the treatment of cancer worth £280,490.
The government is collaborating with pharmaceutical company Novartis to launch a clinical trial for new cholesterol treatment.
People with minor illnesses or who need medicine urgently have been referred to local pharmacies, relieving pressure on doctors.
A framework for the assessment of the impact of rescheduling cannabis-based products for medicinal use (CBPMs).
MHRA update on metformin medicines.
A drug alert has been issued to retailers and healthcare professionals as 4 companies are recalling batches of certain over-the-counter Ranitidine medicines used to treat conditions such as stomach ulcers and heartburn.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).